Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionJump Financial, LLC
Latest Disclosed Ownership20,266 shares
Latest Disclosed Value $ 1,229,133
Jump Financial, LLC reports 117.49% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 14, 2026 - Jump Financial, LLC filed a 13F-HR form disclosing ownership of 20,266 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,062,344 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 9,318 shares of Bristol-Myers Squibb Company. This represents a change in shares of 117.49% during the quarter. The current value of the position is $961,216 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Bristol-Myers Squibb Common Stock 110122108 20,266 10,948 117.49 1,229 144.82 0.0146
2026-02-17 2025-12-31 13F Bristol-Myers Squibb Common Stock 110122108 9,318 -205,402 -95.66 503 -94.82 0.0062
2025-11-13 2025-09-30 13F Bristol-Myers Squibb Common Stock 110122108 214,720 214,720 9,684 0.1159
2025-08-13 2025-06-30 13F Bristol-Myers Squibb Common Stock 110122108 0 -7,188 -100.00 0 -100.00
2025-05-14 2025-03-31 13F Bristol-Myers Squibb Common Stock 110122108 7,188 7,188 438 0.0060
2025-02-13 2024-12-31 13F Bristol-Myers Squibb Common Stock 110122108 0 -4,500 -100.00 0 -100.00
2024-11-14 2024-09-30 13F Bristol-Myers Squibb Common Stock 110122108 4,500 -443,771 -99.00 233 -98.75 0.0047
2024-11-14 2024-06-30 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 448,271 420,110 1,491.81 18,617 1,119.12 0.3720
2024-08-14 2024-06-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 448,271 420,110 18,617 0.3720
2024-05-13 2024-03-31 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 28,161 -145,584 -83.79 1,527 -82.87 0.0418
2024-10-21 2023-12-31 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 173,745 166,245 2,216.60 8,915 1,949.20 0.2933
2024-02-07 2023-12-31 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 173,745 166,245 8,915 0.2946
2024-10-21 2023-09-30 13F/A-2 BRISTOL-MYERS SQUIBB COM 110122108 7,500 1,000 15.38 435 4.82 0.7920
2024-10-21 2023-09-30 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 11,359 4,859 659 0.0153
2023-11-07 2023-09-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 11,359 4,859 659 0.0252
2024-10-21 2023-06-30 13F/A-2 BRISTOL-MYERS SQUIBB COM 110122108 6,500 6,500 416 0.8169
2024-10-21 2023-06-30 13F/A-1 BRISTOL-MYERS SQUIBB Common Stock 110122108 34,006 34,006 2,175 0.0473
2023-08-07 2023-06-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 34,006 34,006 2,175 0.0819
2022-11-07 2022-09-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 0 -4,451 -100.00 0 -100.00
2022-08-09 2022-06-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 4,451 4,451 343 0.0148
2024-09-06 2022-03-31 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 0 -4,643 -100.00 0 -100.00
2022-05-12 2022-03-31 13F Bristol-Myers Squibb Common Stock 110122108 0 -4,643 0
2022-02-10 2021-12-31 13F Bristol-Myers Squibb Common Stock 110122108 4,643 -9,132 -66.29 290 -64.46 0.0182
2021-11-12 2021-09-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 13,775 6,203 81.92 816 61.26 0.0590
2021-08-13 2021-06-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 7,572 -37,134 -83.06 506 -82.07 0.0489
2021-05-17 2021-03-31 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 44,706 44,706 2,822 0.2636
2021-02-12 2020-12-31 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 0 -15,033 -100.00 0 -100.00
2020-11-13 2020-09-30 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 15,033 15,033 907 0.1822
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.